Abstracts

INVESTIGATING THE ROLE OF CAPSID STABILITY IN INNATE IMMUNE SENSING OF HIV-1 CORES

Background: The emergence of antiretroviral drug resistance has hindered progress toward combatting the ongoing HIV/AIDS epidemic. A promising drug target, HIV-1 capsid (CA) is a genetically fragile protein that plays essential roles throughout the viral replication cycle. We recently demonstrated that destabilization of the CA lattice increases the propensity to form aberrant virus particles. In…

PREDICTIVE VALIDITY OF POPULATION MODELS FOR LINEZOLID EXPOSURE AND TOXICITY IN ZeNix

Background: Previously, using data from Nix-TB (NCT02333799, N&#3f104), we published models relating linezolid exposure to peripheral neuropathy (PN) and hemoglobin (Hb), and we suggested how those models might guide patient management to reduce linezolid-related toxicity. Effective application of model-based insights to patient care requires model validation on independent data. Here we assess the predictive validity…

VESATOLIMOD PHARMACODYNAMIC RESPONSE IS ASSOCIATED WITH TIME TO HIV REBOUND

Background: Vesatolimod (VES) is a well-tolerated toll-like receptor 7 agonist that was associated with a modest delay in time-to-HIV-rebound (TTHR) during analytical treatment interruption (ATI) in HIV viremic controllers. This analysis evaluated VES exposure in relation to pharmacodynamic (PD) biomarkers and TTHR, as well as the associations among VES pharmacokinetics (PK)/PD, PD biomarkers and TTHR.…

HIV COINFECTION INCREASES HBV-INDUCED HEPATIC FIBROGENESIS THROUGH HIF-1α

Background: The progression of chronic HBV to cirrhosis is accelerated by HIV coinfection compared to HBV mono-infection. HIV and gp120 signal through CCR5 and CXCR4 on hepatocytes and hepatic stellate cells to promote cell growth and proliferation through hypoxia-inducible factor-1α (HIF-1α). HIF-1α has been shown to regulate expression of the pro-fibrogenic cytokine TGF-β1. We hypothesize…

ALIGNMENT OF PrEP USE WITH HIV RISK IN YOUNG WOMEN AND MEN IN UGANDA

Background: Oral daily pre-exposure prophylaxis (PrEP) uptake has been high but discontinuation is very common and often happens soon after initiation. Whether discontinuation among young women and their male partners aligns with potential exposure to HIV is unknown. Methods: Young women ages 16-25 and their male partners were enrolled in separate but linked longitudinal studies…

RACIAL/ETHNIC DISPARITIES IN TIMELY ANTIRETROVIRAL THERAPY INITIATION: 2007-2019

Background: Integrase inhibitor (INSTI)-containing antiretroviral therapy (ART) is currently the guideline-recommended first-line treatment for HIV. Delayed initiation of INSTIs may amplify racial and ethnic inequities in health outcomes among people with HIV. We therefore estimated racial/ethnic differences in ART initiation and INSTI prescription among adults newly entering HIV care in the United States from 2007-2019.…